Infographic | September 26, 2022

Global Landscape Of Advanced Therapies In 2022

Source: Citeline
Gene therapy iStock-1300754583

More than one in six drugs in development today are based upon sophisticated gene, cell or RNA modalities. The continued development of genetic technologies gives rise to a broad and diverse pipeline, pioneered by biotechs, encompassing a range of novel drug platforms. The proliferation of advanced therapies is pioneered by biotechs that specialize in a particular technology. Large pharmaceutical companies selectively add the most promising candidates to their pipelines, sourced from a range of companies and modalities.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene